Wyeth Prevnar Batches To Ship Soon; Contract Fill/Finish Facility Approved
Wyeth plans to release batches of Prevnar from a Cardinal facility in early May following FDA approval of the third-party vial fill and finish line April 16
More from Archive
More from Pink Sheet
England’s health technology assessment institute explains how its sandbox environment is helping to test new evaluation methods for drugs or indications with which it does not have experience, such as metabolic dysfunction-associated steatohepatitis.
The European Medicines Agency, like its counterpart in the US, is increasingly focusing on the use of alternatives to animal testing.
Industry is concerned that Prasad may make regulatory flexibility tougher to obtain for cell and gene therapy, while vaccine and public health advocates are angry about Prasad’s criticisms of US COVID-19 policies.